Robotic
surgery, also known as robot assisted surgery, is an emerging
advanced medical technology which helps specialist surgeons perform
many types of complex procedures with more accuracy, control, and
flexibility as compared to the conventional procedures. Robotic
surgeries are associated with minimally invasive surgical procedures.
Surgical robots have overcome the limitations of the current
laparoscopic procedures and enhanced the benefits of minimally
invasive surgeries.
ROBODOC
by Integrated Surgical Supplies Ltd. was the first surgical robot
approved by the FDA in August 2008. It was first used to place the
femur, with better precision, in hip replacement surgeries, now it
has been used in more than 28000 joint replacement procedures.
Similarly several other robotic systems such as AESOP system (a
voice-controlled robotic endoscope), Da Vinci, and Zeus have been
approved by the FDA. Robotic surgery using the Da Vinci Surgical
System was approved by the U.S. FDA in 2000 and has been adopted in
the U.S. and Europe hospitals for treating various conditions.
Mechanical arm and camera arm with surgical instruments are
extensively used for clinical robotic surgery providing the surgical
team with a 3-D view of the surgical site. The robotic surgery market
is rapidly expanding. New projects have been launched on corporate
and academic levels for the development of miniaturized, lightweight
prototypes of surgical robots.
Read
Report Overview @
https://www.transparencymarketresearch.com/robotic-surgery-market.html
Global
Robotic Surgery Market: Drivers and Restraints
In terms of components, the robotic surgery system market is
segmented into surgical systems, robotic surgery services, and
instruments & accessories. Robotic surgery services segment is
expected to expand at a rapid pace. High maintenance cost and annual
service contract which comes with the product at the time of sale are
expected to boost the segment. The instruments & accessories
segment is expected to hold a major market share due to the rise in
adoption of robots assisted surgeries. Based on application or area
of surgery, the market is segmented into laparoscopy, gynecology,
urology, orthopedic, pediatric surgery, general surgery, and others.
Robotic
surgical system is anticipated to offer immense alternatives in
urology, thoracic, colorectal, gynecological, general and pediatric
surgeries. Urology accounted for a major share of this market due to
the rise in prostatectomy procedures. Basis on end-user, the robotic
surgery market is segmented into hospitals and ambulatory surgical
centers. Hospital segment accounted for a major share due to the
availability of the trained professional surgical team for performing
these surgeries along with advanced infrastructure.
Global
Robotic Surgery Market: Key Segments
In terms of geography, the robotic surgery market is segmented into
North America, Europe, Asia pacific, Latin America, and Middle East &
Africa. North America is expected to dominate the market due to the
increase in acceptance of these robotics by patients, advanced health
care infrastructure, and strategic collaboration with insurance
companies. Asia Pacific is expected to be the next biggest market
after North America due to rapid development of robotic surgical
systems and increase in demand of surgical robots in countries such
as China and India. The global market is dominated by established
companies and increasing competition in factors such as pricing,
distribution partnership, product and technology upgrade.
Request
Report TOC@
https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=39626
Global
Robotic Surgery Market: Key Players
Key players operating in the robotic surgery market include Intuitive
Surgical Inc., MAKO Surgical Corp., Medtronic Inc., Accuray
Incorporated, Hansen Medical Inc., Blue Belt Technologies, Mazor
Robotics Ltd., SRI International, Curexo Technology Corporation, and
Think Surgical Inc.
No comments:
Post a Comment